Podcasts Weekly Economics Podcast: Vaccine Nationalism Ayeisha Thomas-Smith is joined by Common Wealth's Miriam Brett and Tahir Amin from the Initiative for Medicines, Access & Knowledge By Ayeisha Thomas-Smith 15 February 2021 By the middle of January, 49 wealthy countries had administered 39 million doses of the Covid vaccine. But the world’s poorest countries had only done 25 jabs, all of them in just one country: Guinea. Not 25 million, not 25,000 — just 25. Why can’t some countries get hold of the vaccine? Why are rich countries buying more doses than they need?
Topics:
Ayeisha Thomas-Smith considers the following as important:
This could be interesting, too:
Robert Vienneau writes Austrian Capital Theory And Triple-Switching In The Corn-Tractor Model
Mike Norman writes The Accursed Tariffs — NeilW
Mike Norman writes IRS has agreed to share migrants’ tax information with ICE
Mike Norman writes Trump’s “Liberation Day”: Another PR Gag, or Global Reorientation Turning Point? — Simplicius
Weekly Economics Podcast: Vaccine Nationalism
Ayeisha Thomas-Smith is joined by Common Wealth's Miriam Brett and Tahir Amin from the Initiative for Medicines, Access & Knowledge
15 February 2021
By the middle of January, 49 wealthy countries had administered 39 million doses of the Covid vaccine. But the world’s poorest countries had only done 25 jabs, all of them in just one country: Guinea. Not 25 million, not 25,000 — just 25.
Why can’t some countries get hold of the vaccine? Why are rich countries buying more doses than they need? And are we seeing the rise of ‘vaccine nationalism’?
In this episode, Ayeisha is joined by Miriam Brett, director of research and advocacy at Common Wealth and Tahir Amin, co-executive director of Initiative for Medicines, Access & Knowledge.
- For more, read Common Wealth’s report on what’s wrong with our IP system.
- And Tahir’s piece for Foreign Affairs is available here.
Listen on Google podcasts
Listen on Apple podcasts
Image: Pixabay